ArticleFrontiers in genetics2026

Off-target drug repurposing for rare and ultra-rare cancers: towards a scalable therapeutic framework.

Gehan Premaratne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.